Atypical hemolytic uremic syndrome and eculizumab therapy in children
Hemolytic uremic syndrome (HUS) is often encountered in children with acute kidney injury. Besides the well-known shiga toxin-producing Escherichia coli-associated HUS, atypical HUS (aHUS) caused by genetic complement dysregulation has been studied recently. aHUS is a rare, chronic, and devastating...
Saved in:
Main Authors: | Seong Heon Kim (Author), Hye Young Kim (Author), Su Young Kim (Author) |
---|---|
Format: | Book |
Published: |
Korean Pediatric Society,
2018-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rapid Resolution of Atypical Hemolytic Uremic Syndrome by Eculizumab Treatment
by: Min Seung Kim, et al.
Published: (2020) -
Neonatal Atypical Hemolytic Uremic Syndrome in the Eculizumab Era
by: Sara Madureira Gomes, et al.
Published: (2021) -
Meningococcal Carriage in Children with Atypical Hemolytic Uremic Syndrome Receiving Eculizumab Therapy
by: Asli Kavaz Tufan, et al.
Published: (2024) -
A Case of associated Hemolytic Uremic Syndrome with DIC
by: Seong Heon Kim, et al.
Published: (2015) -
A Multicenter Study Evaluating the Discontinuation of Eculizumab Therapy in Children with Atypical Hemolytic Uremic Syndrome
by: Saeed AlZabali, et al.
Published: (2022)